Cargando…
Preclinical study of a DNA vaccine targeting SARS-CoV-2
To fight against the worldwide COVID-19 pandemic, the development of an effective and safe vaccine against SARS-CoV-2 is required. As potential pandemic vaccines, DNA/RNA vaccines, viral vector vaccines and protein-based vaccines have been rapidly developed to prevent pandemic spread worldwide. In t...
Autores principales: | Hayashi, Hiroki, Sun, Jiao, Yanagida, Yuka, Otera, Takako, Kubota-Koketsu, Ritsuko, Shioda, Tatsuo, Ono, Chikako, Matsuura, Yoshiharu, Arase, Hisashi, Yoshida, Shota, Nakamaru, Ryo, Ju, Nan, Ide, Ryoko, Tenma, Akiko, Kawabata, Sotaro, Ehara, Takako, Sakaguchi, Makoto, Tomioka, Hideki, Shimamura, Munehisa, Okamoto, Sachiko, Amaishi, Yasunori, Chono, Hideto, Mineno, Junichi, Komatsuno, Takao, Saito, Yoshimi, Rakugi, Hiromi, Morishita, Ryuichi, Nakagami, Hironori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020527/ https://www.ncbi.nlm.nih.gov/pubmed/35489099 http://dx.doi.org/10.1016/j.retram.2022.103348 |
Ejemplares similares
-
Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats
por: Hayashi, Hiroki, et al.
Publicado: (2023) -
Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction
por: Hayashi, Hiroki, et al.
Publicado: (2023) -
Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant
por: Hayashi, Hiroki, et al.
Publicado: (2022) -
AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
por: Tenma, Akiko, et al.
Publicado: (2019) -
A novel angiotensin II peptide vaccine without an adjuvant in mice
por: Nakamaru, Ryo, et al.
Publicado: (2021)